Knowledge Management Tools for Genetic Variation Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and interpreting genetic abnormalities, particularly copy number variations, face challenges due to ascertainment bias and limited resolution, leading to inaccurate diagnosis and treatment, especially in distinguishing between normal and disease-associated variations.
Innovation Solution
Development of Normal Variation Knowledge Management Tools (KMTs) that utilize array Comparative Genomic Hybridization (aCGH) data and comprehensive relational databases to generate software tools for interpreting chromosomal changes, providing population frequencies and association data for phenotypes and disease states, enabling accurate diagnosis and personalized medicine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If array CGH technology is used to detect copy number variations, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent introduces Knowledge Management Tools (KMTs) as an intermediary layer between the array CGH detection system and clinical interpretation. The KMTs include comprehensive databases that store normal variation frequencies and disease associations, serving as a mediator that translates complex array CGH data into clinically actionable information without requiring direct complex interpretation by clinicians
Solution Approach 2:
The patent creates comprehensive databases that copy and store population-level genetic variation data from array CGH studies. These databases serve as reference copies that can be queried to determine whether detected copy number variations are normal or disease-associated, eliminating the need for clinicians to directly analyze complex population genetics data
2Reliability
If comprehensive databases with large population data are created, then reliability of diagnosis is improved, but loss of time in data compilation increases
Solution Approach 1:
The patent performs preliminary actions by pre-compiling comprehensive databases of normal copy number variation frequencies from large population studies before clinical use. The databases are prepared in advance with curated information about which variations are benign and which are disease-associated, so that during clinical practice, clinicians can quickly query pre-analyzed data rather than performing new compilations
Solution Approach 2:
The KMTs implement feedback mechanisms where database contents are continuously refined based on new array CGH data and clinical outcomes. The system learns from accumulated cases to improve the accuracy of distinguishing normal from disease-associated variations, with the feedback loop reducing compilation time over successive iterations
3Object-affected harmful factors
If population frequency data is used to interpret copy number variations, then object-generated harmful factors are reduced, but loss of information occurs
Solution Approach 1:
The patent changes the parameter of population frequency thresholds dynamically. Instead of using fixed cutoff values, the KMTs adjust interpretation thresholds based on the specific copy number variation detected, the population being tested, and the clinical context. This allows the system to reduce ascertainment bias while preserving relevant individual case information through context-dependent parameter adjustment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The KMTs enable clinicians to determine the significance of copy number variations, reducing subjective interpretation and facilitating personalized treatment by linking genomic variations to drug efficacy and adverse reactions, thereby improving diagnostic accuracy and treatment outcomes.
Implementation Method 1
Over the past several years array comparative genomic hybridization (array CGH) has demonstrated its value for analyzing DNA copy number variations
Data Source
AI summary
The present invention relates to genetic analysis and evaluation utilizing copy-number variants or polymorphisms. The methods utilize array comparative genomic hybridization and PCR assays to identify the significance of copy number variations in a human, non-human animal, and plant subject or subject group.